Viewing StudyNCT00072566



Ignite Creation Date: 2024-05-05 @ 11:33 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00072566
Status: COMPLETED
Last Update Posted: 2015-05-12
First Post: 2003-11-04

Brief Title: Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Key Dates - Follows AllAPIJSON File Order

Start Date: 2003-12
Start Date Type: None
Primary Completion Date: 2008-11
Primary Completion Date Type: ACTUAL
Completion Date: 2008-11
Completion Date Type: ACTUAL
First Submit Date: 2003-11-04
First Submit QC Date: November 4 2003
Study First Post Date: 2003-11-05
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2015-05-12
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-05-08
Last Update Post Date: 2015-05-12
Last Update Post Date Type: ESTIMATED